Panacea Biotec peers

Companies like Panacea Bioteclatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

PANACEABIO₹329.05

Panacea Biotec Limited

· Pharma & Health
₹ CrorePeersSAIPARENTHIKALINDOCODCALWINDLASHESTERBIOSOLARASYNCOMFMcap ₹2,017 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
PANACEABIO
FY26
SAIPARENT
FY26
HIKAL
FY26
INDOCO
FY26
Peer
Average
Valuation — at last close
P/E—111.02×——111.02×
P/B2.42×4.36×◆ 2.08×2.10×2.85× -15%
EV/EBITDA◆ -420.68×52.86×14.35×20.94×29.38× -1532%
Market Cap₹2,017 Cr₹2,139 Cr₹2,496 Cr₹1,973 Cr₹2,202 Cr -8%
Growth
Revenue CAGR 3Y◆ 11.63%—-5.40%3.41%-1.00% +1269%
Revenue CAGR 5Y0.47%—-0.09%◆ 8.25%4.08% -88%
Revenue YoY (latest Q)◆ 19.72%—5.89%7.32%6.61% +199%
Net Income YoY (latest Q)-44.44%—66.96%◆ 311.40%189.18% -123%
Profitability
EBITDA Margin-0.73%10.16%◆ 12.87%7.68%10.24% -107%
Net Income Margin-1.12%◆ 3.74%-2.85%-5.35%-1.49% +25%
Return on Common Equity-0.64%◆ 2.91%-3.97%-9.70%-3.59% +82%
Return on Capital Employed-4.11%2.57%◆ 3.30%0.97%2.28% -280%
Return on Assets-0.56%◆ 1.00%-1.99%-3.93%-1.64% +66%
Credit & Quality
Total Debt/Equity◆ 0.03×0.65×0.57×1.11×0.78× -96%
Interest Coverage-6.23×◆ 1.18×0.91×0.13×0.74× -942%
Scale — latest FY
Revenue / Total Income₹640 Cr₹381 Cr₹1,713 Cr₹1,845 Cr₹1,313 Cr -51%
Net Income−₹7.2 Cr₹14.3 Cr−₹48.8 Cr−₹98.7 Cr−₹44.4 Cr +84%
Total Assets₹1,262 Cr₹1,424 Cr₹2,365 Cr₹2,593 Cr₹2,128 Cr -41%
EPS₹-0.88₹4.36₹-3.96₹-10.7₹-3.43 +74%
Book Value per Share₹136.19₹111.08₹97.07₹101.76₹103.3 +32%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.